...
| WMDA Standard | Title and link to document | Explanation | Status | |
|---|---|---|---|---|
3.13 4.09 | Unrelated hematopoietic stem cell donors as research subjects Bone Marrow Transplantation (2011), 46: 10-13 | Discuss various implications of research participation of unrelated stem cell donors in research protocols. | Current (2017) | |
| 10.13 | Donor and liability of donor registries, donor centres and collection centres-recommendations Bone Marrow Transplantation (2004), 33: 467-470 | The paper outlines the ethical aspects of liability of involved parties and the need for insurance coverage. The article has shortcoming with the respect to legal advices. | Under review (2017), for more details: | |
| 5.04.1 | Transfusion Medicine and Hemotherapy (2017), 44: 407-413 | An educational paper to explain why GRID is implemented on a global scale. | Current (2018) | |
| 5.04.1 | GRID: Moving to Unique Donor Identifier | A public webpage with educational materials to implement GRID in a registry | Current (2018) | |
2.11 2.11.1 | WMDA Quality Manual | A template quality manual for organisations that prepare for WMDA Qualification/Accreditation | Current (2017) | |
| Related donors | Family donor care management: principles and recommendations Bone Marrow Transplantation (2010) 45: 1269-1273 | This document hopes to encourage increased collaboration between those caring for related and unrelated donors, and build on the extensive work, which has already been undertaken in this field to homogenize care. | Current (2017) | |
| Related donors | Related hematopoietic cell donor care: is there a role for unrelated donor registries? Bone Marrow Transplantation (2015) 50: 637-641 | Paper outlining ways how to enhance and homogenise related donor care. | Current (2018) | |
| 1.07 | 1.07 | Criteria for Evaluation of Transplant Centres | Develop criteria and a form to evaluate TCs in the following situations:
TC does not need to evaluated if the following apply:
| Under development |
| 1.06 | Donor centre Audit | Create guidelines and checklists to audit donor centres | Under development |
...
| WMDA Standard | Title and link to document | Explanation | Status | ||
|---|---|---|---|---|---|
3.22 3.22.2 | Bone Marrow Transplantation 49:880-886 Guidance for assessing the medical suitability for adult volunteer donors | The paper provides a background to unrelated adult donor and recipient safety, recommends a common framework for assessing the health of unrelated adult donors at each stage of the donation pathway and presents a novel mechanism for sharing international consensus criteria for individual medical and lifestyle conditions. The guidance below reflects the consensus opinion provided by the WMDA donor medical suitability committee. The purpose of this guidance is to provide globally harmonised medical assessment criteria which simultaneously protect the interest of donors whilst ensuring the safety of cellular products across international boundaries. | Current (2017) | ||
| 3.02 | Bone Marrow Transplantation (2013) 48: 1480150 | Paper This paper is providing recommendations regarding qualifications and training of recruiters. At the moment, the online recruitment is not described in this paper. | Update required. | ||
| 2.08 | Key Performance | 2.08 | Key Performance Indicators for Registries | WMDA has defined five Key Performance Indicators that represent the key activities of stem cell donor registries. These key performance indicators are calculated annually from the WMDA Global Trends Report data. | Current (2018) |
| 3.03, 3.04, 3.09, 6.07, 6.07.1, 3.24, 10.11, 10.13 | Bone Marrow Transplantation (2010) 45: 832-838 | This paper is providing information about the donor care standards of the WMDA. The paper has been published in 2010, the wording of the WMDA Standards might have changed over time. | Current (2017) | ||
...
| WMDA Standard | Title and link to document | Explanation | Status | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.04, 3.05, 3.06, 3.09, 3.10.1, 3.11, 3.11.1, 3.13, 3.15 | Bone Marrow Transplantation (2003) 31: 539-545 | This is a checklist to set up an informed consent at the various stages. The paper has been replaced by the WMDA Guidance to explain the WMDA Standards. The guidance can be found at: https://share.wmda.info/x/0wB7Cw | Out of date | ||||||||||||
Bone Marrow Transplantation (2010), 45:819-824 | WMDA has developed online documentation to explain the accreditation process, which is available at WMDA Share under the pillar: 'Ensuring Quality' | Out of date | |||||||||||||
International exchange of cord blood units; the registry aspects Bone Marrow Transplantation (2010), 45: 825-831 | Replaced by chapter 6 of the WMDA handbook: a gift of life | Out of date | |||||||||||||
| 8.05 | Haematologica (2011): 96:942-943 | The aim of this paper is to review the basis of regulatory approval of the biosimilar G-CSF agents, including the available safety data, with reference to the indication for mobilization of PBSC in normal donors and to make recommendations based on these. The recommendation has been updated in 2017. | Out of date | ||||||||||||
3.22 | Bone Marrow Transplantation (20082015) 4250: 9334-14340 | This paper is an update from the statement issued by WMDA in 2007. On the basis of an assessment of a continuing lack of evidence for an increased risk of malignancy in donors receiving G-CSF, the WMDA has re-issued a more reassuring statement. The recommendation has been updated in 2017 This document describes criteria for permanent or temporary deferral, guidelines for risk evaluation of infectious disease, examples of conditions requiring assessment and questionnaires designed to elicit relevant information about a donor's medical history and general health. The paper has been updated in 2014. | Out of date | ||||||||||||
3.22 3.22.2 | Overview of registries, HLA typing and diversity, and search algorithms Tissue Antigens (2007) 69: 3-5 | This paper is to inventorize the registries HLA typing methods and quality control used to evaluate the accuracy of typing results. | Out of date | 5.02 | World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplantation ( 20072008) 3942: 7379- 74114 | This document describes criteria for permanent or temporary deferral, guidelines for risk evaluation of infectious disease, examples of conditions requiring assessment and questionnaires designed to elicit relevant information about a donor's medical history and general health. The paper has been updated in 2014. This paper is updated in 2012, find here the link to the updated publication: https://www.nature.com/articles/bmt201393 | Out of date | ||||||||
Overview of registries, HLA typing and diversity, and search algorithms Tissue Antigens (2007) 69: 3-5 | This paper is to inventorize the registries HLA typing methods and quality control used to evaluate the accuracy of typing results. | Out of date | |||||||||||||
| 5.02 | Bone Marrow Transplantation (2007) 39:737-741 | This paper is updated in 2012, find here the link to the updated publication: https://www.nature.com/articles/bmt201393 | Out of date | ||||||||||||
International Journal of Immunogenetics (2005) 32:19-69 | The paper provides information on the serological equivalents of DNA typings. The paper has been updated in 2009. It is recommended to visit the IMGT/HLA website for the most recent information. | Out of date | European Journal of Immunogenetics (2001) 28: 565-596 | The paper provides information on the serological equivalents of DNA typings. The paper has been updated in 2004. It is recommended to visit the IMGT/HLA website for the most recent information. | The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Human Immunology (1999) 11: 1157-1181International Journal of Immunogenetics (2005) 32:19-69 | The paper provides information on the serological equivalents of DNA typings. The paper has been updated in 20012009. It is recommended to visit the IMGT/HLA website for the most recent information. | Out of date | ||||||||
| search for HLA-matched donors | HLA-A*, -B*, -DRB1 | * | and ‐DQB1 alleles and their association with serologically defined | HLA-A, -B, -DR antigens.Tissue Antigens (1997) 50: 401-418HLA‐A, ‐B, ‐C, ‐DR and ‐DQ antigens European Journal of Immunogenetics (2001) 28: 565-596 | The paper provides information on the serological equivalents of DNA typings. The paper has been updated in | 20012004. It is recommended to visit the IMGT/HLA website for the most recent information. | Out of date | Bone Marrow Transplantation (2004) 34: 97-101 | This paper described the procedures and responsibilities of the search for international unrelated donors. The paper has been replaced by the WMDA Handbook: A gift for life. | Out of date | Haematopoietic Stem Cell Registries: WMDA definitions of a donor center | This paper has been replaced by the paper: "Qualifications and training of adult stem cell donor recruiters" | Out of date | ||
Human Immunology (1999) 11: 1157-1181 | The paper provides information on the serological equivalents of DNA typings. The paper has been updated in 2001. It is recommended to visit the IMGT/HLA website for the most recent information. | Out of date | |||||||||||||
Tissue Antigens (1997) 50: 401-418 | The paper provides information on the serological equivalents of DNA typings. The paper has been updated in 2001. It is recommended to visit the IMGT/HLA website for the most recent information. | Out of date | |||||||||||||
Bone Marrow Transplantation (2004) 34: 97-101 | This paper described the procedures and responsibilities of the search for international unrelated donors. The paper has been replaced by the WMDA Handbook: A gift for life. | Out of date | |||||||||||||
| Haematopoietic Stem Cell Registries: WMDA definitions of a donor center | This paper has been replaced by the paper: "Qualifications and training of adult stem cell donor recruiters" | Out of date | |||||||||||||
Bone Marrow Transplantation (1997) 20: 621–629 | One of the first WMDA publications describing donor work-up. | Out of date | |||||||||||||
Blood (1994) 84: 2833-2389 | This paper amplifies the previous publication and gives special attention to accreditation of national “hubs” (defined as coordinating centers for each country) and donor, harvest, and transplant centers, details of the marrow harvest procedure, use of peripheral blood (PB) stem cells for allografting, and use of PB lymphoid cells for treatment of leukemia relapsing after BMT. Historical document where the WMDA Standards are presented. | Out of date | |||||||||||||
Bone marrow transplants using volunteer donorsDonor work-up and transport of bone marrow--recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups . The Executive Committee of the World Marrow Donor Association (WMDA). Bone Marrow Transplantation (19971992) 20: 621–629 | Historical paper of WMDA, the first publication, outlining the hub conceptOne of the first WMDA publications describing donor work-up. | Out of date | |||||||||||||
| Page Tree | ||||
|---|---|---|---|---|
|